J. Essif

Yuanhuacine Is a Potent and Selective Inhibitor of the Basal-Like 2 Subtype of Triple Negative Breast Cancer with Immunogenic Potential

R. Cichewicz, S. Cai, A. L. Risinger, 2021, Cancers.

Modulation of taxane binding to tubulin curved and straight conformations by systematic 3'N modification provides for improved microtubule binding, persistent cytotoxicity and in vivo potency.

F. Gago, J. Díaz, F. Josa-Prado, 2023, European journal of medicinal chemistry.